Pharmaceuticals and Medical Research (TRBC)

Airbus takes control of Bombardier CSeries in rebuff to U.S. threat

Airbus takes control of Bombardier CSeries in rebuff to U.S. threat

Published 17/10/2017

Airbus SE has agreed to buy a majority stake in Bombardier Inc's CSeries jetliner program, giving a powerful boost to the Canadian plane and train maker in its costly trade dispute with Boeing Co. [more…]

Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors

Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors

Published 17/10/2017

An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines. [more…]

Regeneron-Sanofi drug succeeds mid-stage study

Regeneron-Sanofi drug succeeds mid-stage study

Published 16/10/2017

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. [more…]

U.S. judge in Texas invalidates Allergan patents on Restasis

U.S. judge in Texas invalidates Allergan patents on Restasis

Published 16/10/2017

A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent. [more…]

Exelixis drug improves overall survival in liver cancer patients

Exelixis drug improves overall survival in liver cancer patients

Published 16/10/2017

Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. [more…]

Allergan settles with one of four companies contesting Restasis patent

Allergan settles with one of four companies contesting Restasis patent

Published 12/10/2017

Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court. [more…]

FDA panel backs gene therapy for rare form of blindness

FDA panel backs gene therapy for rare form of blindness

Published 12/10/2017

Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. [more…]

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

Published 12/10/2017

The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. [more…]

China to speed up drug approvals, will accept overseas trial data

China to speed up drug approvals, will accept overseas trial data

Published 09/10/2017

China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market. [more…]

Flexion`s knee pain drug gets FDA nod, shares hit life high

Flexion`s knee pain drug gets FDA nod, shares hit life high

Published 06/10/2017

Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday. [more…]